FOLLOWING THE ONSET OF EXERCISE, the dynamic increase in pulmonary oxygen uptake (V O 2p ) is slowed in patients with chronic obstructive pulmonary disease (COPD) compared with age-matched controls (12, 34, 36, 40, 41, 45) . The slowed kinetics of V O 2p leads to greater reliance on oxygen-independent metabolic pathways and accumulation of by-products that might be related to increased muscle fatigability (e.g., phosphate and H ϩ ) (38) . Thus the slow increase in V O 2p may be mechanistically associated with the marked decrement in exercise tolerance that characterizes this patient population (1, 3, 30, 33, 42, 44) .
Derangements in the diffusive and convective transport of O 2 to skeletal muscle mitochondria (44, 45) and intramyocyte metabolic machinery (3, 54) could explain the slowness of V O 2 kinetics in COPD. During moderate-intensity (sub-"lactate threshold") exercise, the existing literature suggests that V O 2 kinetics are limited by intramyocyte perturbations associated with COPD (34, 40, 45) . However, a different scenario may emerge during heavy (supra-"lactate threshold") exercise. In this situation, higher ventilation and disturbances in mechanics of breathing (1, 2, 49, 50) , hypoxemia (36, 45) , pulmonary hemodynamics (14) , autonomic balance (26) , and peripheral vasodilation (see DISCUSSION for details) could slow the response of systemic (central) and peripheral (microvascular) O 2 delivery to a point where the kinetics of V O 2 might become limited by O 2 availability (38) .
In this context, it can be anticipated that, if COPD slows the dynamic increase in muscle microvascular O 2 delivery (Q O 2 mv ) to a greater extent than the rate of O 2 utilization, as indicated by the V O 2 response following the onset of exercise, muscle microvascular O 2 extraction would be accelerated (9, 16, 18) . In this circumstance, the microvascular pressure of O 2 might transiently reach levels sufficiently low to impair O 2 transfer from capillary to mitochondria (38) , predisposing the kinetics of V O 2 to O 2 delivery (convective and/or diffusive) limitation (39) . In contrast, if the rate of increase in muscle microvascular O 2 extraction is slowed in COPD patients at the onset of exercise, it would suggest that muscle O 2 delivery is in excess of utilization throughout this transitional phase. These responses have been interpreted as V O 2 kinetics being limited by activation of intracellular metabolic pathways (5, 10) . This issue has been explored in healthy aging (9, 15, 16) and some chronic diseases [e.g., diabetes (6) , peripheral arterial disease (5) , and heart failure (10) ]. However, the effects of COPD on the dynamics of (estimated) muscle microvascular O 2 extraction and central cardiovascular responses following the onset of heavy exercise remain unclear.
The main hypothesis tested in the present study is that the sluggish kinetics of V O 2p commonly found in COPD patients are accompanied by faster adjustment of skeletal muscle deoxygenation (or estimated O 2 extraction) and slower "central" cardiovascular dynamics [cardiac output (Q T)] following the onset of heavy-intensity exercise. Our secondary aims were to determine whether 1) an indicator of the dynamics of Q O 2 mv is associated with the kinetics of Q T (approximately systemic O 2 delivery); and 2) the ability of COPD patients to sustain exercise of heavy intensity is related to the kinetics of V O 2p during the same exercise bout.
METHODS

Subjects
The study population comprised 10 men with clinical and functional diagnosis of COPD, according to the Global Initiative for Obstructive Lung Disease (GOLD) criteria (33) , and 11 age-and sex-matched sedentary controls. The patients were a subgroup of individuals referred from the outpatient clinic of our institution to participate on a larger clinical trial. Subjects were considered for study inclusion if the gas exchange threshold (GET) had been previously identified in a progressive exercise test (see below). Inclusion criteria for COPD patients were as follows: forced expiratory volume in 1 s (FEV1)-to-forced vital capacity ratio Ͻ0.7 and postbronchodilator FEV1 Ͻ 60% predicted; resting arterial PO2 Ͼ 60 Torr at room air; no evidence of severe pulmonary hypertension (estimated systolic pulmonary arterial pressure Ͻ40 mmHg) and preserved left ventricular function (ejection fraction Ͼ60%) by echo-Doppler cardiography; and clinical stability for at least 3 mo before the study and no use of oral steroids in the preceding 6 mo. Subjects in the control group were free of chronic pulmonary, cardiovascular, immune, and metabolic disease. Before entering the study, all healthy controls were submitted to clinical evaluation, and they were screened by pulmonary function tests, analysis of blood biochemistry, electrocardiography, echocardiography, and a stress exercise testing. To minimize the confounding effects of regular physical activity on the pathophysiology of exercise intolerance in COPD, we studied only patients and healthy controls who were sedentary during the year preceding admission to the study.
All participants signed a written, informed consent form. The study protocol was approved by the Medical Ethics Committee of the Federal University of São Paulo/São Paulo Hospital, Brazil.
Study Protocol
Subjects performed a ramp-incremental exercise test (5-10 W/min in patients and 15-20 W/min in controls) to determine parameters of aerobic function during exercise (52) . The tests were performed on an electronically braked cycle ergometer (Corival 400, Lode) at 60 rpm, and they were preceded by an unloaded baseline pedaling at 0 W for 2 min.
The difference between V O2p at the GET (V O2p GET) and V O2p at peak exercise (V O2p peak) (⌬V O2p peak-GET) was determined from the ramp test. On a separate day, subjects performed a constant work rate exercise test at the same pedaling rate to the Tlim (min) at an intensity chosen to elicit a V O2p that exceeded the V O2p GET by a value of ϳ40 -50% of the ⌬V O2p peak-GET (ϳ75% peak work rate). Tlim was defined as the time point in which the patients signaled to stop exercising or could not maintain the required pedaling rate for 10 s, despite being encouraged by the investigators.
Measurements
Pulmonary function tests. Spirometric tests were performed by using the CPF System (Medical Graphics-MGC, St. Paul, MN), with airflow being measured by a calibrated Pitot tube (PreVent Pneumotach). The subjects completed at least three acceptable maximal forced and slow expiratory maneuvers after the inhalation of 400 g of salbutamol via metered-dose inhaler. Forced vital capacity (liters), FEV1 (liters), and inspiratory capacity (liters) were recorded. Carbon monoxide diffusing capacity was measured by the single-breath technique, and "static" lung volumes were obtained by body plethysmography. Arterial partial pressure for O2 and CO2 were determined in standard anaerobic conditions (Torr).
Exercise tests. V O2p (ml/min), pulmonary carbon dioxide output (V CO2p; ml/min), minute ventilation (V E; l/min), and end-tidal partial pressures for O2 and CO2 (Torr) were measured breath by breath using a computer-based system (CardiO2 System, Medical Graphics). Gas exchange variables measured during the incremental test were averaged every 15 s, and V O2p peak was defined as the highest value achieved during the test. Heart rate (HR; beats/min) was determined using the R-R interval from a 12-lead electrocardiogram. Arterial oxyhemoglobin saturation was determined by pulse oximetry [(Sp O 2 ), %; POX 010-340, Mediaid, Torrance, CA] with its analog signal being directed to the system. Subjects were also asked to rate their "shortness of breath" at exercise cessation using the 0 -10 Borg's category ratio scale. The V O2p GET was estimated by the gas-exchange method, inspecting visually the inflection point of V CO2p with regard to V O2p (modified V-slope) (8) and by the ventilatory method when V E-to-V O2p ratio and end-tidal partial pressure of O2 increased, while V E-to-V CO2p ratio and end-tidal partial pressure of CO2 remained stable. The reading was performed independently by two experienced observers without knowledge of other results or subject identities.
Skeletal muscle oxygenation. Skeletal muscle oxygenation profiles of the left vastus lateralis were evaluated with a commercially available near-infrared spectroscopy (NIRS) system (Hamamatsu NIRO 200, Hamamatsu Photonics KK). The theory of NIRS has been described in detail elsewhere (17) . Briefly, one fiber-optic bundle carried the near-infrared light produced by the laser diodes to the tissue of interest, while a second fiber-optic bundle returned the transmitted light from the tissue to a photon detector in the spectrometer. The intensity of incident and transmitted light were recorded continuously and, along with the relevant specific extinction coefficients, used to measure changes in the oxygenation status of hemoglobin ϩ myoglobin (Hb ϩ Mb). A set of optodes was placed on the belly of the vastus lateralis muscle midway between the lateral epicondyle and greater trochanter of the femur. The optodes were housed in an optically dense plastic holder, thus ensuring that the position of the optodes, relative to each other, was fixed and invariant. The optode assembly was secured on the skin surface with tape and then covered with an optically dense, black vinyl sheet, thus minimizing the intrusion of extraneous light and loss of near-infrared light.
The variables assessed by NIRS are the concentration of oxygenated, deoxygenated, and total Hb. Among the NIRS variables, several laboratories have adopted the deoxy-Hb/Mb signal (deoxy-Hb concentration [HHb] ) as the preferred indicator of changes in muscle microvascular oxygenation during exercise (15, 16, 19, 24, 28) . The [HHb] response to exercise is then considered a proxy of O 2 extraction in the microcirculation, reflecting the balance between O 2 delivery and utilization. The device used herein did not measure the reduced scattering of the tissue, preventing determination of absolute values of [HHb] (in M). Therefore, the [HHb] values were recorded as a change (⌬) from baseline in units of micromoles per centimeter. The NIRS system was "zeroed" during the unloaded cycling portion of the tests.
Central hemodynamics. Q T (l/min) and stroke volume (SV; liters) were measured noninvasively throughout the constant work rate test using impedance cardiography (PhysioFlow PF-05, Manatec Biomed-ical). The PhysioFlow device and its methodology have been thoroughly described elsewhere (13) . Before each exercise test, the system was autocalibrated, taking into consideration age, stature, body mass, and blood pressure values. Signal quality was verified by visualizing the ECG tracing and its first derivative and the impedance waveform with its first derivative. In preliminary experiments, the coefficient of variation for changes in Q T and SV during exercise were 3.3 and 4.1%, respectively. In these preliminary trials, the changes in Q T measured by impedance cardiography were consistent with those predicted from V O2p values using the submaximal Q T-V O2p relationship described in COPD patients (data not shown) (29, 35) .
Kinetics Analysis
The breath-by-breath V O2p, Sp O 2 , NIRS oxygenation, and hemodynamic (Q T, SV, and HR) data were interpolated second by second before kinetics analysis (SigmaPlot 10.0, Systat Software, San Jose, CA). The V O2p responses to exercise in the intensity domain used in our investigation are characterized by the presence of a slow component, which may also be observed in Q T measurements. Based on our experience with pulmonary gas exchange responses to exercise in COPD patients, we anticipated that determination of the onset or emergence of the slow component in this population would require ensemble averaging of several transitions. Since we used data from a single transition (see Methodological Considerations), we opted to fit V O2p, Q T, SV, and HR data from 30 s of baseline pedaling to 180 s after the onset of exercise. Using this approach and Eq. 2 (see below), we ensured that the same amount of data was included in the kinetic analysis of V O2p and hemodynamics for each subject (controls and patients), minimizing model-dependent effects on our results. For [HHb] kinetics, the analyses were conducted on data from 30-s baseline cycling to the first 60 s following the increase in work rate to minimize distortion of the curve-fitting seen when longer periods are analyzed (15, 16, 18, 19) . Theoretical (18) and empirical studies (15, 16, 24) suggest the primary phase of the HHb response is complete within this time window. To reduce the potential influence of low Sp O 2 values on [HHb] in the patient group, the following correction ([HHb] corr) was applied:
The model used for fitting the kinetic response of V O2p, Q T, SV, HR, and [HHb] was
where [Y] is the variable under analysis the subscripts b and p are baseline unloaded cycling and primary component, respectively; and A is amplitude, TD is time delay, and is time constant of the exponential response of interest. In the analysis of Q T, HR, and SV, the TD p was dropped from the equation. For V O2p analysis, we deleted the data relative to the first 20 s after exercise onset, i.e., the cardio-dynamic phase (34) . Therefore, pV O2p represents the time course of the primary component of the response, an estimate of the muscle V O2 kinetics (23, 53) . The overall kinetics of [HHb] (approximate time to reach 63% of the response following the onset of exercise) were determined by the mean response time (MRT ϭ ϩ TD). In addition, the amplitude of the "slow component" of V O2p, Q T, and [HHb] was estimated as the change from 3 min to the end of exercise (end-3Ј) (39) .
Statistical Analysis
The SPSS version 13.0 statistical software was used for data analysis (SPSS, Chicago, IL). Results were summarized as means Ϯ SD, or median and ranges for symptom scores. To contrast betweensubject resting and exercise responses, nonpaired t or Mann-Whitney tests were used, as appropriate. One-way ANOVA was used to contrast MRT values: a post hoc analysis was performed with Scheffé's test when appropriate. Pearson's product-moment correlation was used to assess the level of association between continuous variables. A z-test was used to determine if the amplitude of the slow component of V O2p, Q T, and [HHb] was significantly different from zero. The level of statistical significance was set at P Ͻ 0.05 for all tests.
RESULTS
Subject Characteristics and Exercise Tolerance
Subjects' resting characteristics are presented in Table 1 . There were no between-group differences in age and body mass index. As expected from the inclusion criteria, patients had moderate-to-severe airflow obstruction with increased "static" lung volumes and moderate reductions in carbon monoxide diffusing capacity. Seven patients were classified as GOLD stage II, with the remaining patients being considered as GOLD stages III-IV (33).
V O 2p peak , peak work rate, and V O 2p GET were significantly reduced in patients compared with controls; in contrast, V E-tomaximal voluntary ventilation ratio and dyspnea scores were higher in patients (Table 2) . Six patients had exercise-related oxyhemoglobin desaturation, i.e., Sp O 2 decrease Ն4% (lowest values at peak exercise ranging from 86 to 89%). The tolerance to high-intensity, constant work rate exercise (T lim ) was significantly reduced in patients compared with controls (640 Ϯ 95 s vs. 371 Ϯ 100 s; P Ͻ 0.001). In similarity with the maximal exercise test, V E-to-maximal voluntary ventilation ratio and dyspnea were higher in patients, with six patients showing a significant decrease in Sp O 2 (lowest values at exercise cessation ranging from 86 to 88%).
Pulmonary Gas Exchange and Cardiovascular Adjustments
Representative responses of V O 2p and Q T are shown in Figs. 1 and 2 , respectively. The dynamics of V O 2p were slower in patients than controls (Table 3, Fig. 3 ). In asub- Values are means Ϯ SD; n, no. of subjects. COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; TLC, total lung capacity; RV, residual volume; IC, inspiratory capacity; DLCO, lung diffusing capacity for carbon monoxide; PaO 2 and PaCO 2 , arterial PO2 and PCO2, respectively; SaO 2 , arterial O2 saturation. *P Ͻ 0.05. group of subjects in whom the tests were repeated (4 patients and 5 controls), the coefficient of variation for V O 2p averaged 6.8 and 8.4%, respectively. There was a significant inverse relationship between V O 2p and T lim in COPD patients (r ϭ Ϫ0.70, P Ͻ 0.01; Fig. 4 ) and when data from all subjects were pooled together (r ϭ Ϫ0.56, P Ͻ 0.05). As expected, a V O 2p "slow" component was found in all subjects (P Ͻ 0.05). There were no between-group differences in the magnitude of the V O 2 slow component [⌬V O 2p (end-3Ј) ϭ 202 Ϯ 99 vs. 185 Ϯ 89 ml/min for patients and controls, respectively], and the relationship between ⌬V O 2p (end-3Ј) and T lim was not significant in either group (P Ͼ 0.05).
The increase in Q T was slower in patients compared with controls and longer than those of V O 2p in both groups (Table 3 , Fig. 3 ). To gain further insights into the slowing of Q T of COPD patients, we evaluated the kinetics of HR and SV (Fig. 5) . The dynamics of both variables were significantly slower in patients compared with controls (HR: 61.4 Ϯ 14.2 vs. 86.7 Ϯ 13.9 s; SV: 42.3 Ϯ 10.1 vs. 64.3 Ϯ 11.0 s, P Ͻ 0.01). In similarity with V O 2p , a slow component of Q T was found in all subjects (P Ͻ 0.05). There were no significant differences in the magnitude of the Q T slow component in patients and controls [⌬Q T (end-3Ј) ϭ 1.74 Ϯ 0.51 vs. 1.61 Ϯ 0.70 l/min, respectively]. Moreover, ⌬Q T (end-3Ј) and T lim were not significantly related in either group (P Ͼ 0.05).
Muscle Oxygenation Responses
The dynamics of Sp O 2 -corrected [HHb] values for a representative patient and a normal control are shown in Fig. 6 . As previously described, the [HHb] response displayed a region in which the signal remained stable or decreased transiently (determined here by the time delay) (e.g., Fig. 6 ). All subjects showed a transient decrease in [HHb] early into the exercise, with similar duration in both groups (Table 3) . After this phase, the [HHb] increased rapidly with response kinetics that were faster than the V O 2p and Q T responses in both groups (Table 3 , Fig. 3 ).
[HHb] (Table 3 ) and MRT- [HHb] (Fig. 3) were significantly faster in patients compared with normal controls.
A slow-component of [HHb] was observed in all subjects of the control group ⌬[HHb] (end-3Ј) (P Ͻ 0.05). In contrast, only four patients displayed a slow component of the [HHb] response. The ⌬[HHb] (end-3Ј) was significantly related to ⌬V O 2p (end-3Ј) in the control group (r ϭ 0.72, P Ͻ 0.01), but not in patients (P ϭ 0.38).
Dynamics of Estimated Q O 2 mv
We also calculated an indirect index of the dynamics of Q O 2 mv (Q O 2 mv ϳ V O 2p /MRT[HHb]) (see DISCUSSION for further elaboration). This ratio was significantly higher in patients compared with controls (4.9 Ϯ 1.2 vs. 2.5 Ϯ 0.6, respectively; P Ͻ 0.01), suggesting that Q O 2 mv adapted at a slower rate in patients. Interestingly, Q O 2 mv was closely related to MRT-Q T (Fig. 7) , suggesting that the dynamics of Q O 2 mv followed the response characteristics of systemic ("central") O 2 delivery.
DISCUSSION
Several aspects make this study a novel investigation. Specifically, this is the first study to measure V O 2p , Q T, and tissue oxygenation kinetics simultaneously following the onset of heavy-intensity leg cycling exercise in patients with moderate-to-severe COPD. This is the initial step to establish if key determinants of the dynamic matching of central and peripheral (microvascular) O 2 delivery-to-V O 2 are impaired by COPD and set the stage for future interventional studies. We found that V O 2p kinetics were slower in COPD patients than in controls and correlated with the tolerance to sustain heavy-intensity exercise. In addition, compared with the age-matched controls, COPD patients displayed slower kinetics of Q T and faster dynamics of [HHb] . Interpretation of the latter as an estimate of muscle microvascular O 2 extraction suggests that the dynamics of muscle Q O 2 mv were slower in COPD patients. Accordingly, a qualitative index of Q O 2 mv kinetics (ratio of V O 2p to MRT[HHb]) was greater in COPD patients and was closely related to the overall kinetics of Q T . These data, therefore, indicate that impaired central and peripheral cardiocirculatory adjustments following the onset of heavy-intensity exercise negatively impact the dynamic matching of O 2 delivery and utilization in patients with COPD. Values are means Ϯ SD with the exception of symptoms (median and range); n, no. of subjects. V O2, oxygen uptake; V CO2, carbon dioxide output; RER, respiratory exchange rate; GET, gas exchange threshold; V E, minute ventilation; MVV, maximal voluntary ventilation; Spo 2 oxyhemoglobin saturation by pulse oximetry. *P Ͻ 0.05 (between-group differences in a given exercise testing protocol).
V O 2p Kinetics and Tolerance to Heavy-intensity Exercise
Several groups have reported that V O 2p kinetics are slowed by healthy aging (9, 11, 15, 16) , and this could be due to impairments in the dynamics of O 2 delivery (15, 16) . In general, data from our control group describing the kinetics of V O 2p and central cardiovascular responses to heavy exercise are in close agreement with previous studies (9, 11, 15, 16) . In COPD patients, the kinetics of V O 2p during moderate-intensity (sublactate threshold) exercise are ϳ45-65% slower than in healthy aged controls (34, 36, 40) . We extended these findings to show that V O 2p kinetics during heavy-intensity exercise were, on average, ϳ74% slower in COPD patients (Table 3) . Moreover, phase II V O 2p kinetics displayed an inverse relationship with tolerance to sustain heavy-intensity exercise (Fig. 4) . These data are consistent with those from the study of PuenteMaestu and coworkers (40) , who found a significant inverse correlation between increase in T lim during moderate exercise and the decrease in V O 2p induced by exercise training in patients with advanced COPD. Our data and those of PuenteMaestu et al. (40) collectively suggest that abnormalities on muscle energetics following the onset of exercise may contribute to the patient's ability to sustain dynamic exercise for prolonged periods of time. Thus resolution of factors that promote the slowing of V O 2p response in COPD might prove to be useful in guiding therapeutic efforts to increase the tolerance to heavy-intensity exercise in this population.
Potential Mechanisms for a Slower V O 2p Kinetics at Heavy-intensity Exercise in COPD
The factors generally considered as limiting the kinetics of V O 2 are the adequacy of O 2 delivery during the transient phase following the onset of exercise (27) and/or the activity of intracellular biochemical reactions that stimulate mitochondrial V O 2 , also called "metabolic inertia" (23) . Several groups emphasize the role of O 2 delivery limitation to V O 2 kinetics in the elderly (9, 15, 16) and in chronic diseases (5, 6, 10) . The argument for O 2 delivery limitation of V O 2 kinetics in old subjects is based on slower adaptation of HR (16) and agerelated changes in arteriolar vasodilation (7) . More recently, these arguments have been strengthened by faster kinetics of muscle deoxygenation at the onset of heavy-intensity exercise in old compared with young individuals (9, 15, 16) , suggesting that, in the former group, the dynamics of muscle perfusion were slower in relation to the kinetics of muscle V O 2 (18) . Moreover, interventions that appear to increase muscle oxygenation promoted a speeding of V O 2p kinetics in the elderly (15) . If derangements in O 2 delivery explain, at least partially, the slowing of V O 2 kinetics with healthy aging, it is conceivable that any pathological condition that could further slow the Patients with COPD have decreased oxidative enzyme activity and mitochondrial volume density and an increase in the percentage of type II fibers (as reviewed in Ref. 3 ). This intrinsic skeletal muscle dysfunction could, at least partially, explain the slowing of V O 2p kinetics in COPD patients. Consistent with this notion, V O 2p kinetics of COPD patients performing moderate exercise were not affected by hyperoxic gas breathing (45) , which was assumed to increase muscle O 2 delivery. Moreover, exercise training speeded the kinetics of V O 2p with no effect on HR dynamics, which is usually considered an indicator of Q T (and O 2 delivery) kinetics (12) . Thus, in lieu of similar O 2 delivery following the onset of heavyintensity exercise, intrinsic skeletal muscle dysfunction would solely explain the slower V O 2p kinetics observed in the present study (Figs. 1 and 3) . Several variables measured and estimated in our study suggest this may not be the case during heavyintensity exercise in patients with moderate-to-severe COPD.
Dynamics of Q T During Dynamic Exercise in COPD
A slower adjustment of HR to moderate exercise in patients with COPD than in age-matched controls has been previously described (34, 40) . Numerous factors (see below) can also impair the adjustment of SV following the onset of exercise in COPD, such that HR dynamics may underestimate the impact of the disease on the kinetics of Q T. Our study is the first to show that Q T (approximately O 2 delivery) kinetics were ϳ44% slower in COPD patients compared with healthy peers. This was a consequence of slower SV and HR kinetics, where, on average, the SV response appeared to be affected to a greater extent than HR (ϳ52 vs. ϳ40% higher time constant). This demonstrates that central cardiovascular responses that help maintain the adequacy of O 2 delivery to contracting muscles are impaired in COPD. In the present study, these derangements are unlikely to be related to intrinsic cardiovascular disease, as the patients were clinically and functionally screened for significant inotropic dysfunction and severe pulmonary hypertension.
Potential explanations for slower on-transient Q T (i.e., HR and SV) kinetics in COPD are as follows: 1) autonomic imbalance (26) , 2) pulmonary vascular alterations (including pulmonary hypertension) (14) , and/or 3) effects of mechanics of breathing on SV (1, 2, 49, 50 ). The increase in HR through sympathetic activation is slower than that accomplished by parasympathetic withdrawal (51) . The shift toward greater sympathetic activity with COPD (26) would promote slowing of HR and thereby Q T dynamics. Regarding the SV response, the deleterious cardio-circulatory consequences of increasing Values are means Ϯ SD. V O2p, pulmonary V O2; Q T, cardiac output; ͓HHb͔, deoxyhemoglobin concentration; A, amplitude; , time constant; TD, time delay. *P Ͻ 0.01. lung volumes in patients with COPD, especially during exercise, have been emphasized (1). More specifically, the development of high mean intrathoracic pressures as V E increases in the transitional phase could dynamically impair the rate of right ventricle filling and left ventricle emptying in these patients. Recently, Vogiatzis et al. (49) showed that normal subjects breathing with simulated expiratory flow limitation, similar to that found in advanced COPD, had significantly slower offtransient V O 2p kinetics compared with control values, suggesting that alterations in the mechanics of breathing can reduce muscle O 2 delivery enough to affect the kinetics of V O 2p .
Another relevant mechanism for a reduced O 2 delivery to the working muscles could be related to the pattern of respiratory muscle recruitment in patients with advanced COPD. Aliverti and Macklem (1) postulated that slowing the velocity of shortening of the abdominal expiratory muscles, by increasing expiratory pressures, had major adverse effects on the circulation impeding venous return and decreasing Q T. Considering that some patients seem to recruit massively the abdominal muscles (2), it is conceivable that these adjustments could impair peripheral O 2 delivery. Moreover, respiratory muscle work during heavy exercise can divert a fraction of the Q T from leg muscles, contributing to exercise intolerance (25) . Since the work of breathing is particularly increased in COPD patients (1) , following the onset of exercise, a larger portion of Q T may be directed to the diaphragm, predisposing to slower kinetics of peripheral muscle blood flow in COPD compared with controls. These findings support the notion that central cardiovascular responses to exercise and peripheral O 2 delivery can be Fig. 5 . Heart rate (top) and stroke volume (bottom) dynamics at the onset of heavyintensity exercise in a representative agematched control (left) and a patient with COPD (right). Note that both responses were slower (higher MRT ϭ ϩ TD) in the COPD patient compared with the control subject. bpm, Beats/min. significantly impaired by abnormal pulmonary-mechanical responses in patients with moderate-to-severe COPD.
Kinetics of Muscle Oxygenation
Tissue oxygenation kinetics during exercise are probably the most relevant assessment to determine the effects of COPD on the dynamic supply of O 2 in relation to V O 2 of the muscle. The finding that [HHb] kinetics were faster than the phase II V O 2p and Q T dynamics in both COPD patients and controls is in close agreement with data from previous investigations in young (15, 19, 24) and old adults (15, 16 ). This appears to stem from differences in the profile of muscle V O 2 (monoexponential) and muscle O 2 delivery (a biphasic response) (18, 38, 39) . The faster increase in [HHb] in patients than controls, an estimate of muscle microvascular O 2 extraction kinetics (16, 18, 24) , suggests that any cardiovascular dysfunction related to COPD was sufficient to impair the dynamic matching of muscle Q O 2 mv and V O 2 during the on-transient phase of heavy exercise (Figs. 3 and 6) .
The slowing of Q T reported here is a feasible explanation for the sluggish increase in Q O 2 mv and speeding of [HHb] response. This theory is supported by the close association between the kinetics of Q T and our qualitative index of Q O 2 mv dynamics (V O 2p /MRT[HHb]) (Fig. 7) . However, a temporally reduced O 2 availability could also be related to impaired muscle microvascular function in response to exercise in patients with COPD, independent of the central cardiovascular dysfunction (see above). Heightened sympathetic vasoconstriction at rest will slow the increase in muscle blood flow (48) . Among the known muscle vasodilatory mediators, much emphasis has been given to nitric oxide (NO), especially in disease states. Blockade of NO synthase hastens the increase in O 2 extraction in healthy rat muscles (20) . Furthermore, it has been demonstrated that conditions associated with vascular endothelial dysfunction and reduced vascular NO availability, such as diabetes (6) , aging (9, 46) , and heart failure (10), are characterized by slowing of muscle O 2 delivery and speeding of the increase in microvascular O 2 extraction during contractions. Surprisingly, there is a lack of data on peripheral endothelial function in COPD patients. However, COPD patients are usually former smokers, have increased plasma levels of tumor necrosis factor-␣, and reactive oxygen species (as reviewed in Ref. 21 ). All of these factors will contribute to lower NO availability, predisposing the patients to microvascular dysfunction (55) . Therefore, although the sluggish increase in muscle Q O 2 mv may be determined mainly by the central cardiovascular effects of COPD that slows the kinetics of Q T, as suggested by Fig. 7 , microvascular dysfunction should not be neglected in these patients.
In our older controls, muscle deoxygenation displayed a slow-component response similar, and directly related, to that observed in V O 2p . This is in close agreement with studies in younger subjects (15, 16) and consistent with the notion that most of the slow-component observed in the V O 2p response comes from the exercising legs (37 
Methodological Considerations
Due to the noninvasive nature of our study, several methodological aspects need further clarification. First and foremost, we assumed that the kinetics of deoxy-Hb/Mb measured at a single site reflects the time course of muscle microvascular O 2 extraction following the onset of exercise. Although there is ongoing controversy regarding the primary determinant of the NIRS signal (31, 47) , several studies have used [HHb] from a single site in the quadriceps muscle as a proxy of tissue "fractional" O 2 extraction (6, 15, 16, 18, 19, 24) and provided extensive discussion on this topic. A key argument supporting the use of [HHb] as an approximation of O 2 extraction dynamics is the generally similar characteristics of [HHb] response in humans (15, 16, 18, 19, 24) compared with O 2 extraction dynamics measured in skeletal muscles (9, 10, 23) and calculated in computer simulations (18) . In addition, the NIRS technology employed in our study does not allow measurement of tissue-scattering properties. This prevented calculation of absolute values of [HHb] , but it is unlikely that it would have affected the kinetics profile of HHb compared with results yielded by measuring scattering and incorporating it in our calculations (31) .
Other important issues are the use of data from a single transition to determine differences in V O 2p , Q T, and [HHb] kinetics, and assumption that the primary component of V O 2p kinetics represents the dynamics of muscle V O 2 in COPD patients. Although the use of one transition may limit resolution of small differences in kinetic responses, especially for V O 2p and Q T, the differences between COPD and controls were large enough to be detected statistically, as suggested by the study of Puente-Maestu et al. (41) . The kinetics of the primary component of V O 2p response is widely used as an indicator of the muscle V O 2 response, as the time course of the primary component has been shown (24) or predicted (4) to closely reflect (within 10%) the muscle V O 2 response. Grassi et al. (24) , for instance, found a close similarity between the kinetics of leg V O 2 and V O 2p during cycling exercise, and Rossiter et al. (43) demonstrated that phosphocreatine breakdown (from 31 P-NMR), which is considered to be closely linked to mitochondrial O 2 consumption (32), followed a similar dynamic profile to that of the primary component of V O 2p during moderateintensity exercise. However, slowing of muscle blood flow may create a discrepancy between muscle and pulmonary V O 2 kinetics, where the V O 2p response will become faster than the muscle V O 2 dynamics due to changes in the leg-to-lung transit delay (39) . Therefore, based on the Q T and [HHb] kinetics determined in our study, we may have underestimated the slowness of muscle V O 2 kinetics in patients with COPD performing heavy-intensity exercise.
Conclusions
In general, our data show that patients with moderate-tosevere COPD have impaired central and peripheral cardiovascular responses to exercise that lead to slower kinetics of Q T and faster muscle deoxygenation profile following the onset of heavy-intensity exercise. The latter effects are in opposite direction to that expected to be seen when the slowing of V O 2p kinetics occur due only to intrinsic muscle metabolic disturbances, and there is a surplus of O 2 delivery to contracting muscles. Our interpretation of the data, therefore, is that derangements in convective O 2 delivery to skeletal muscles might contribute substantially to limit the kinetics of V O 2p and exercise tolerance during heavy-intensity exercise in patients with moderate-to-severe COPD. However, without knowing the absolute values of microvascular PO 2 following the onset of contractions, and if those were low enough to impair O 2 transfer from blood to muscle, we cannot establish with certainty that the slothful kinetics of V O 2p in COPD were a consequence of reduced O 2 availability. This can be resolved by studies examining the effects of interventions that increase muscle O 2 delivery, or speed its dynamics, on the kinetics of V O 2 at high-intensity exercise in patients with COPD.
